BAT: A Revolutionary Garment Enhancing Radiation Safety for Healthcare Professionals

 

On September 23, 2024, Burlington Medical announced the availability of BAT, a groundbreaking radiation protection garment designed to significantly reduce the risk of breast cancer and other radiation-associated cancers among healthcare workers. This innovative garment covers crucial areas such as the breast, axilla, and thyroid.

Developed by Dr. Lauren Ramsey, a Breast Surgical Oncologist, BAT was inspired by a personal loss. Dr. Ramsey's friend and colleague succumbed to breast cancer, which she believed was exacerbated by occupational radiation exposure. Addressing a dire need within the medical community, BAT offers an additional layer of protection that is often missed by traditional radioprotective aprons.

Dr. Ramsey highlights the increased risk faced by female healthcare professionals, particularly noting, "Female orthopedic surgeons have up to a three times higher risk of developing breast cancer." With women now comprising 55 percent of medical school attendees, the design of BAT is tailored specifically with their safety in mind. It achieves over 97 percent reduction in radiation exposure to the upper outer quadrant of the breast and also lessens exposure to the thyroid, chest, and spine.

Key benefits of BAT include:

• Targeted Protection: BAT is meticulously crafted to shield the breast, axilla, and thyroid, cutting down radiation exposure by up to 97.7 percent.
• Comfort and Mobility: Featuring a lightweight design with mesh panels, BAT ensures comfort, freedom of movement, and temperature control.
• Compatibility: Designed to be worn with any radioprotective apron, BAT requires no additional attachments, making it a versatile and essential addition to any healthcare professional's safety gear.
• Enhanced Safety: Besides safeguarding the breast and axilla, it also minimizes scatter radiation that can impact the chest, neck, and spine.

Exclusively distributed by Burlington Medical, BAT stands out as a vital innovation in the field of healthcare safety, offering a critical solution to reduce cancer risks associated with ionizing radiation exposure, which accumulates over time. This garment empowers healthcare workers by providing effective protection without compromising on comfort or mobility.

Healthcare professionals can directly place orders at: https://burmed.com/store/bat.html

___________

RadParts, a TTG Imaging Solutions Company, is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/ 

 

Research Advocates for Advanced Precision Radiation Therapy in Lung Cancer

 

A new study from The University of Texas MD Anderson Cancer Center advocates for the use of intensity-modulated radiotherapy (IMRT) over 3D-conformal radiotherapy (3D-CRT) in treating unresectable, locally advanced non-small cell lung cancer (NSCLC). Published in JAMA Oncology, the study reveals that IMRT leads to fewer severe side effects, such as pneumonitis, while delivering similar survival outcomes compared to 3D-CRT. This finding is based on a secondary analysis of long-term data from 483 patients enrolled in the Phase III NRG Oncology-RTOG 0617 trial.

The research highlights the technological advancements in IMRT, which unlike the older 3D-CRT that uses straight radiation beams, employs complex computational methods to modulate radiation beams, allowing for a more precise targeting of tumors and sparing of normal tissue. Despite concerns about the long-term effects of low-dose radiation exposure from IMRT, the study confirms that this does not lead to increased secondary cancers or toxicity over time. This makes IMRT a preferable choice in the management of NSCLC, noted for its precision over the rudimentary 3D-CRT, which has been in use for over 50 years.

Statistical analysis of the study data shows that patients treated with IMRT had slightly better, though not statistically significant, five-year overall and progression-free survival rates compared to those treated with 3D-CRT. Even patients with larger or unfavorably located tumors near the heart showed improved outcomes with IMRT. The study emphasizes the need to minimize cardiac exposure during radiation planning, linking lower heart exposure to better median survival rates.

Endorsed by lead author Stephen Chun, the study supports a shift towards prioritizing IMRT in lung cancer treatment, similar to its adoption in other cancers like prostate and brain tumors. This shift reflects a broader move towards maximizing treatment precision to improve patient outcomes while reducing side effects. The research was supported by the National Institutes of Health and other organizations, reinforcing its findings within the oncological community.

For top-quality, user-friendly, and affordable parts support for linear accelerators and radiation equipment, reach out to the experts at RadParts.

RadParts, a TTG Imaging Solutions Company, is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: www.cpsmi.com

Israeli Child Receives Pioneering Seated Proton Therapy with Innovative System

P-Cure is pioneering a groundbreaking approach in the field of proton therapy with its latest achievement: the treatment of a young child diagnosed with ocular cancer using a novel proton therapy system. This innovative system, which has received FDA clearance and is operational at P-Cure's Clinical Development Center in Israel, allows patients to receive treatments in a seated position. This is a significant milestone, as it marks the first time such a method has been used, catering to patients of all ages and regardless of tumor location.

Developed in collaboration with the Hadassah Medical Center, the system utilizes a gantry-less, intensity-modulated particle therapy technology that is both cost-effective and adaptable to existing Linac room configurations. This collaboration has already led to the successful treatment of 14 cancer patients, showcasing the system's ability to improve patient comfort and quality of life, which are crucial for positive clinical outcomes.

The case of 'D', a four-year-old boy, highlights the system's potential to make advanced cancer treatment more accessible. Despite the challenging circumstances, the family opted for treatment in Israel thanks to the availability of P-Cure's system. The technology's adaptive therapy capabilities allow for real-time adjustments based on tumor and healthy tissue dynamics, ensuring precise and safe treatment delivery.

Moreover, P-Cure's system represents a significant advancement in making proton therapy more widely available. Traditional proton therapy solutions require substantial space and investment, limiting their availability. P-Cure's compact and cost-efficient solution can be integrated into existing cancer treatment facilities, potentially transforming the landscape of cancer care by making high-quality proton therapy accessible to a broader patient population.

For parts and services related to Linear Accelerators and more, contact RadParts!

RadParts, a TTG Imaging Solutions Company, is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: www.cpsmi.com 

Significant Milestone Reached in Compact Particle Accelerator Technology

Researchers, led by The University of Texas at Austin and including international partners and TAU Systems Inc., have made a significant breakthrough in compact accelerator technology by developing a particle accelerator that is under 20 meters long and generates an electron beam with 10 billion electron volts (10 GeV) of energy. This advancement drastically reduces the size of high-energy accelerators, which traditionally span several kilometers. The new compact accelerator opens up potential applications in semiconductor testing, medical imaging and therapy, and scientific research.

The team's technology, an advanced wakefield laser accelerator, utilizes a powerful laser to create plasma waves in helium gas, propelling electrons to high energies. A novel approach involving nanoparticles significantly enhances the efficiency of this process. The researchers aim to apply this technology in various fields, including testing the radiation resistance of space electronics, examining the internal structures of semiconductor chips, developing new cancer treatments, and capturing atomic-scale dynamics with X-ray free electron lasers.

This compact accelerator's design is based on a concept first described in 1979, with recent advancements making it more powerful and practical for broader use. The team envisions future iterations of the accelerator that are even more compact, powered by table-top lasers capable of firing thousands of times per second. This development represents a major leap in making high-energy particle acceleration more accessible and versatile for research and industry.

To learn more, visit the original article posted in phys.org/news

_________________

RadParts, a TTG Imaging Solutions Company, is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: www.cpsmi.com 

Innovative Radiotherapy Method Potentially Halves Treatment Duration for Head and Neck Cancer

A groundbreaking study by the IAEA has found that a new radiotherapy technique for head and neck cancer could significantly shorten treatment times, especially beneficial for low- and middle-income countries (LMICs). This research, the largest of its kind, involved 12 centers across ten LMICs, including Argentina, Brazil, Cuba, India, Indonesia, Pakistan, Philippines, South Africa, Thailand, and Uruguay. The study showed that administering fewer but higher doses of radiation has similar clinical outcomes to standard treatments, potentially halving treatment durations.

This advancement could be a game-changer for LMICs, where head and neck cancer is particularly prevalent, accounting for 76% of global cases and 84% of deaths in 2020. Shorter treatment times mean reduced waitlists, allowing more patients to receive prompt care. This is crucial in LMICs, where challenges like increased demand for radiotherapy, limited resources, and centralized healthcare services in major cities contribute to long waiting periods. Reducing these wait times not only eases patient and family anxiety but also improves survival chances. The findings have been published in the International Journal of Radiation Oncology, Biology, and Physics and align with global initiatives like the IAEA's Rays of Hope, which aims to bolster cancer treatment capabilities in these countries.

What is Radiation Therapy?

The IAEA's HYPNO trial, launched in 2010, has introduced a transformative approach to radiotherapy for head and neck cancer, a disease prevalent in low- and middle-income countries (LMICs). Traditional treatment typically spans seven weeks, but prior studies have explored more intense regimens, either increasing the dose over the same period or maintaining the dose but shortening the duration to five to six weeks. These methods proved safe and effective.

Expanding on these findings, the IAEA's latest research tested an even more intensive method: hypofractionated radiotherapy. This approach administers fewer but higher radiation doses over just four weeks, roughly half the time of standard treatment. In a groundbreaking comparison involving 729 patients, the outcomes and survival rates for those receiving accelerated normo-fractionated and hypofractionated radiotherapy were similar, affirming the latter's efficacy and safety in a shorter timeframe.

The trial's influential results, presented by Professor Søren M. Bentzen at the American Society for Therapeutic Radiology and Oncology's annual meeting, underscore the need for randomized controlled trials in LMICs to establish evidence-based practices. This research exemplifies how international collaboration and the IAEA's role in connecting global cancer centers can lead to significant advancements in radiation oncology. The HYPNO trial's success means that radiation oncologists can now treat more patients effectively and efficiently, offering a practical solution to resource limitations in cancer care.

May Abdel-Wahab, Director of the IAEA Division of Human Health, highlighted the trial's significance in demonstrating the value of funded, multinational research tailored to global cancer needs. This innovation in cancer care, supported by IAEA's initiatives like Rays of Hope Anchor Centres, is crucial in ensuring that patients worldwide receive timely and high-quality treatment.

__________

For high-quality, user-friendly, low-cost parts support for linear accelerators and radiation equipment, contact RadParts.

RadParts, a TTG Imaging Solutions Company, is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: www.cpsmi.com 

WSU Veterinary Hospital Installs a New Linear Accelerator to Fight Cancer

 

Washington State University's Veterinary Teaching Hospital has significantly advanced its cancer treatment capabilities by installing a new linear accelerator (LINAC). This state-of-the-art technology is set to revolutionize the way cancer is treated in pets, offering advanced radiation therapy that can not only prolong lives but potentially cure various cancers.

Dr. Janean Fidel, a veterinary oncologist at WSU, emphasized the transformative potential of this machine in treating a wide range of cancers, including mast cell tumors, soft tissue sarcomas, and cancers affecting the oral, nasal, and brain regions. The new LINAC stands out for its precision in targeting cancer cells while minimizing damage to surrounding healthy tissues, a critical aspect of effective cancer treatment.

The installation of this LINAC, which involved fundraising efforts since 2018 amounting to over $1 million, replaces an older model acquired in 2010. Despite serving over 3,500 animals, the previous machine was plagued with frequent malfunctions. The new LINAC is a technological leap forward, offering enhanced accuracy, speed, and safety. It boasts submillimeter targeting accuracy and high dose rate delivery, greatly improving treatment outcomes by reducing unnecessary radiation exposure to healthy tissue and shortening treatment duration.

A notable feature of the new LINAC is its onboard imaging system, allowing operators to precisely locate tumors just before treatment, ensuring accurate alignment with the radiation beam. This system is a significant upgrade over older models that relied on film for imaging, which was less efficient and offered lower image quality.

The WSU oncology team has undergone extensive training to utilize this advanced machine. Dr. Raelynn Farnsworth, the chief medical officer of the Veterinary Teaching Hospital, expressed gratitude to the donors who acquired this technology. This new equipment is expected to provide exceptional cancer treatment for pets, a rare service in the region.

Reference the original article at WSU.edu/news here.

Need linear accelerator parts or service? Contact RadParts today!

RadParts, a TTG Imaging Solutions Company, is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerators and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost components and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: www.cpsmi.com